ACUMEN PHARMACEUTICALS

Acumen is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target amyloid-beta oligomers, (AβOs), which Acumen believes to be a key underlying cause of Alzheimer’s disease, or AD. Acumen is currently focused on advancing a targeted immunotherapy drug candidate, ACU193, to establish proof of mechanism in early AD patients. Acumen initiated its Phase 1 clinical trial of ACU193 in the second quarter of 2021 with the objective to evaluate its safety and ... tolerability and explore its pharmacokinetics and target engagement. This trial is currently enrolling patients with mild cognitive impairment and mild dementia due to AD. ACU193 Phase 1 data intended to evaluate safety and tolerability and demonstrate clinical proof of mechanism are expected by year end 2022.

#SimilarOrganizations #People #Financial #Website #More

ACUMEN PHARMACEUTICALS

Social Links:

Facebook

Instagram

Industry:

Biotechnology Health Diagnostics Therapeutics

Founded:

1996-01-01

Address:

Carmel, Indiana, United States

Country:

United States

Website Url:

http://www.acumenpharm.com

Total Employee:

11+

Status:

Active

Contact:

+1 6508757772

Email Addresses:

[email protected]

Total Funding:

115.1 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Tag Manager WordPress Wordpress Plugins Sitelinks Search Box Microsoft Exchange Online

Similar Organizations

excision-biotherapeutics-logo

Excision BioTherapeutics

Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.

spero-therapeutics-logo

Spero Therapeutics

Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.

Current Advisors List

laura-stoppel_image

Laura Stoppel Board Member @ Acumen Pharmaceuticals
Board_member

jeffrey-ives_image

Jeffrey Ives Board Member @ Acumen Pharmaceuticals
Board_member
2014-05-01

jeffrey-sevigny_image

Jeffrey Sevigny Board Member @ Acumen Pharmaceuticals
Board_member

not_available_image

Nathan Fountain, MD Board Member @ Acumen Pharmaceuticals
Board_member

sean-stalfort_image

Sean Stalfort Board Member @ Acumen Pharmaceuticals
Board_member

not_available_image

Grant Krafft Scientific Advisor @ Acumen Pharmaceuticals
Advisor
2019-01-01

Current Employees Featured

daniel-j-oconnell_image

Daniel J. O&s;Connell
Daniel J. O'Connell Director, President & CEO @ Acumen Pharmaceuticals
Director, President & CEO
2006-01-01

not_available_image

Russell Barton
Russell Barton Chief Operating Officer @ Acumen Pharmaceuticals
Chief Operating Officer

matt-zuga_image

Matt Zuga
Matt Zuga Chief Financial Officer and Chief Business Officer @ Acumen Pharmaceuticals
Chief Financial Officer and Chief Business Officer
2021-06-01

not_available_image

Daniel O&s;Connell
Daniel O'Connell President & Chief Executive Officer @ Acumen Pharmaceuticals
President & Chief Executive Officer

not_available_image

Eric Siemers
Eric Siemers Chief Medical Officer @ Acumen Pharmaceuticals
Chief Medical Officer

Founder

not_available_image

Grant Krafft

Stock Details

Company's stock symbol is NASDAQ:ABOS

Investors List

pbm-capital-group_image

Official Site Inspections

http://www.acumenpharm.com Semrush global rank: 8.36 M Semrush visits lastest month: 321

Host Informations
Whois Informations

Unable to get host informations!!!

Loading ...